Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Cannabinoids + terpenes** refers to the synergistic combination of cannabinoids (such as THC and CBD) and terpenes (aromatic compounds like beta-caryophyllene, limonene, linalool, beta-pinene, alpha-humulene, and geraniol) found in cannabis, known as the entourage effect, where terpenes modulate and enhance cannabinoid activity for improved therapeutic outcomes. Terpenes contribute aroma, flavor, and independent medicinal properties including anti-inflammatory, analgesic, antimicrobial, antidepressant, anxiolytic, anticancer, and neuroprotective effects, while binding to cannabinoid receptors like CB1 and CB2, mimicking or potentiating cannabinoids without significant psychoactivity or addiction risk. This combination shows promise in preclinical studies for pain relief (including neuropathic and chemotherapy-induced), inflammation, epilepsy, anxiety, depression, and infections, often outperforming isolates.[1][2][3][4][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cannabinoids + terpenes.